INTRAV Trademark

Trademark Overview

On Thursday, September 26, 2019, a trademark application was filed for INTRAV with the United States Patent and Trademark Office. The USPTO has given the INTRAV trademark a serial number of 79271832. The federal status of this trademark filing is REGISTERED as of Tuesday, October 13, 2020. This trademark is owned by Dizlin Pharmaceuticals AB. The INTRAV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating diseases of the central nervous system
intrav

General Information

Serial Number79271832
Word MarkINTRAV
Filing DateThursday, September 26, 2019
Status700 - REGISTERED
Status DateTuesday, October 13, 2020
Registration Number6171926
Registration DateTuesday, October 13, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 28, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating diseases of the central nervous system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 18, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDizlin Pharmaceuticals AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSE
Party NameDizlin Pharmaceuticals AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSE
Party NameDizlin Pharmaceuticals AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSE

Trademark Events

Event DateEvent Description
Saturday, February 20, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, January 29, 2021FINAL DISPOSITION NOTICE SENT TO IB
Friday, January 29, 2021FINAL DISPOSITION PROCESSED
Wednesday, January 13, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 13, 2020REGISTERED-PRINCIPAL REGISTER
Friday, July 31, 2020NOTIFICATION PROCESSED BY IB
Tuesday, July 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 28, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 15, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 15, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 22, 2020ASSIGNED TO LIE
Thursday, June 18, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 20, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 19, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 19, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, February 22, 2020REFUSAL PROCESSED BY IB
Thursday, February 20, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, February 6, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, February 6, 2020REFUSAL PROCESSED BY MPU
Wednesday, January 15, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, January 14, 2020NON-FINAL ACTION WRITTEN
Sunday, December 29, 2019ASSIGNED TO EXAMINER
Friday, November 22, 2019APPLICATION FILING RECEIPT MAILED
Monday, November 18, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 14, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

intrav nervous system central diseases preparations treating pharmaceutical